Hualan Biological Engineering – World Class Benchmarking
Company: Hualan Biological Engineering Incorporated
Bloomberg ticker: 002007 SZ
Market cap: US$5,436m
Background: Hualan Biological Engineering Incorporated produces and markets human serum albumin (HSA), gamma globulin, frozen prothrombin (PCC), and other related biological products.
World Class Benchmarking of Hualan Biological Engineering
- Profitable Growth rank of 3 was up compared to the prior period’s 4th rank
- This is above average performance compared to 410 medium Health Care companies worldwide
- Profitability rank of 3 was better than its Growth rank of 5
- Profitability rank of 3 was the same compared to the prior period’s 3rd rank
- This is above average performance compared to peers
- Growth rank of 5 was up compared to the prior period’s 7th rank
- This is average performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.